Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication after severe asthma. The anti-TSLP antibody has ...

Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published online Oct. 23 in JAMA Otolaryngology-Head & Neck Surgery. Richard G. Chiu, ...

Findings showed treatment with tezepelumab significantly reduced the size of nasal polyps and nasal congestion compared with placebo. The Food and Drug Administration (FDA) has approved Tezspire ® ...

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...

WILMINGTON, DE — AstraZeneca and Amgen have received U.S. Food and Drug Administration (FDA) approval for TEZSPIRE® (tezepelumab-ekko) as an add-on maintenance treatment for adults and adolescents ...

The timeline for recovery from knee revision surgeries is not as regimented as it is for primary knee replacements, and can vary quite a bit from person to person. It may take up to 12 months to fully ...

Lavendaire explains what to expect during LASIK surgery and the recovery process. Secret Service finds 17 'skimming' devices in tour of San Antonio businesses U.S. Eyes Striking Venezuelan Military ...

KUOW is Seattle’s NPR news station. We are an independent, nonprofit news organization that produces award-winning journalism, innovative podcasts, engaging community events, and more.

The Vernon Jubilee Hospital Foundation is once again going to light up the Christmas season. The 39th annual Light A Bulb holiday appeal is officially underway.